Canton Strategic Holdings (CNTN) Net Cash Flow Growth (1y) (2022 - 2026)
Canton Strategic Holdings (CNTN) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 198.34% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 467.41% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14,223.53% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 453.08% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | 1,086.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,086.51% |
| Dec 31, 2025 | 7,272.57% |
| Sep 30, 2025 | 271.98% |
| Jun 30, 2025 | 319.40% |
| Mar 31, 2025 | 0.98% |
| Dec 31, 2024 | -114.71% |
| Sep 30, 2024 | -156.93% |
| Jun 30, 2024 | -258.73% |
| Mar 31, 2024 | 14.73% |
| Dec 31, 2023 | 859.23% |
| Sep 30, 2023 | 35.63% |
| Jun 30, 2023 | 120.26% |
| Mar 31, 2023 | -126.42% |
| Dec 31, 2022 | -2,566.08% |
| Sep 30, 2022 | -12,028.19% |
| Jun 30, 2022 | -24,528.08% |
| Mar 31, 2022 | 6,673.65% |